Skip to main content

First Cohort of Affordable Technologies for Cancer Detection, Diagnosis, and Treatment in LMICs Enters their Second Phase

, by Paul Pearlman & Karen Haney

Under the Affordable Cancer Technologies Program (RF-CA-13-015: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3)), NCI’s Center for Global Health (CGH) supports the development and validation of low-cost, portable technologies with the potential to increase early detection, diagnosis, and non-invasive or minimally invasive treatment of cancer.

This program consists of a two-phase award, and CGH would like to congratulate its first cohort of investigators on transitioning from the validation phase to the build phase of their projects. These investigator teams have achieved their first-phase milestones, and they are now testing their innovative technologies in low- and middle-income countries with their clinical partners:

  • A low-cost enabling technology for image-guided photodynamic therapy of oral leukoplakia - Jonathan Celli and Tayyaba Hasan, Massachusetts General Hospital;
  • High resolution microendoscopy for cervical cancer diagnosis - Kathleen Schmeler, MD Anderson Cancer Center and Rebecca Richards-Kortum, Rice University;
  • Adaptation and testing of the CryoPen cryotherapy device for treating cervical neoplasia for use in low-income settings - Miriam Cremer, Magee-Women’s Research Institute and Foundation;
  • Adapting the Cepheid GeneXpert test to detect HPV - Louise Kuhn, Columbia University;
  • Assessing the performance, safety and efficacy of a new cryotherapy device using liquid CO2 - Jean Anderson, Johns Hopkins.
  • Developing low-cost, portable computer-aided detection and diagnostic (CADD) tools for non-invasive screening of breast cancer patients in remote locations in LMICs – Susan Love, The Dr. Susan Love Research Foundation (Funded by the National Institute of Biomedical Imaging and Bioengineering)

CGH looks forward to seeing the exciting progress of these teams as they enter this new phase of their projects. You can read more details about their technologies here.

For additional information about our affordable technology development programs, please email Paul Pearlman at

< Older Post

Third Cohort joins NCI’s Affordable Cancer Technologies Program: supporting the development of affordable technologies for cancer detection, diagnosis, and treatment in LMICs

Newer Post >

A new focus for the International Cancer Screening Network